Christina M. Ackermann
General Counsel
Bausch & Lomb Corp (BLCO)Equibles does not estimate personal net worth.
Get an email with a short summary when Bausch & Lomb Corp publishes a filing, an earnings call transcript or a press release.
Get BLCO alertsAbout Christina M. Ackermann
Christina M. Ackermann is recorded as General Counsel at Bausch & Lomb Corp (BLCO). The newest filing on record that lists Christina M. Ackermann as General Counsel at Bausch & Lomb Corp (BLCO) is dated March 13, 2023. Christina M. Ackermann was last confirmed as General Counsel at Bausch Health Companies Inc. (BHC) in a filing dated May 2, 2022. The proxy statement of Bausch & Lomb Corp reports total compensation of $6,091,013 for Christina M. Ackermann in fiscal 2023, including a base salary of $246,635. Disclosed compensation is on record for 7 fiscal years. Bausch & Lomb Corp is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Bausch & Lomb Corp includes Thomas J. Appio (CEO and Board Member), Brent Saunders (Chairman), Thomas W. Ross, Sr. (Chairman and Board Member) and 7 others.
Affiliation history
-
Current
Start not stated–present
Last confirmed March 13, 2023
-
Start not stated–2022-05-02
Last confirmed by a filing; no departure on record
Company network
Drug Manufacturers - Specialty & Generic · Healthcare
General Counsel
Leadership on record at Bausch & Lomb Corp
- Thomas J. Appio CEO, Board Member
- Brent Saunders Chairman
- Thomas W. Ross, Sr. Chairman, Board Member
- Sam Eldessouky CFO
- A. Robert D. Bailey General Counsel
- Andrew C. von Eschenbach Board Member
- Barbara Trebbi Board Member
- Brett Icahn Board Member
- Eduardo C. Alfonso Board Member
- Gary Hu Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Bausch & Lomb Corp (BLCO) | Former Executive Vice President & General Counsel and President Ophthalmic Pharmaceuticals | $246,635 | $6,091,013 |
| 2022 | Bausch & Lomb Corp (BLCO) | Former Executive Vice President & General Counsel and President Ophthalmic Pharmaceuticals | $750,000 | $4,735,526 |
| 2021 | Bausch & Lomb Corp (BLCO) | Former Executive Vice President & General Counsel and President Ophthalmic Pharmaceuticals | $750,000 | $4,574,588 |
| 2021 | Bausch Health Companies Inc. (BHC) | Former Executive Vice President and General Counsel and Head of Commercial Operations | $750,000 | $4,574,588 |
| 2020 | Bausch & Lomb Corp (BLCO) | Executive Vice President & General Counsel and President, Ophthalmic Pharmaceuticals | $743,654 | $3,541,028 |
| 2020 | Bausch Health Companies Inc. (BHC) | Former Executive Vice President and General Counsel and Head of Commercial Operations | $743,654 | $3,541,028 |
| 2019 | Bausch Health Companies Inc. (BHC) | Executive Vice President, General Counsel and Head of Commercial Operations | $690,308 | $3,379,932 |
| 2018 | Bausch Health Companies Inc. (BHC) | Executive Vice President, General Counsel and Head of Commercial Operations | $647,539 | $3,386,907 |
| 2017 | Bausch Health Companies Inc. (BHC) | Executive Vice President and General Counsel | $600,000 | $2,795,152 |
Recent activity
No call appearances or filed executive changes recorded yet.